| Literature DB >> 31552159 |
Mikhail Lew P Ver1, John R Dimar1, Leah Y Carreon1.
Abstract
STUDYEntities:
Keywords: classification; dislocation; fracture; fracture-dislocation; lumbar spine; outcomes; surgical treatment; traumatic spondylolisthesis
Year: 2018 PMID: 31552159 PMCID: PMC6745646 DOI: 10.1177/2192568218801882
Source DB: PubMed Journal: Global Spine J ISSN: 2192-5682
Figure 1.Traumatic lumbar spondylolisthesis classification based on anatomic injury (Dimar JR 2nd). Type 1: unilateral or bilateral facet jump/dislocation; Type 2: unilateral or bilateral facet fracture; Type 3: acute unilateral or bilateral pars fracture; Type 4: acute fracture to previous fusion mass; Type 5: bilateral pedicle fracture; Type 6: complex fracture dislocation with vertebral body involvement.
Figure 2.Overview of search strategy based on PRISMA guidelines.
Summary of Cases Included in Review.
| Year | Author | N | Age, Mean (Range) | Injury Type, n (%) | Listhesis Direction, n (%) | Treatment Approach, n (%) | Treatment Type, n (%) | Level of Evidencea | Overall Risk for Biasb |
|---|---|---|---|---|---|---|---|---|---|
| 1956 | Van Demark[ | 1 | 14 | Crush | Anterior | Posterior | PSF | V | Serious |
| 1957 | Robertson[ | 1 | 48 | Crush | Posterior | NO | NO | V | Serious |
| 1957 | Robson[ | 1 | 26 | Crush | Anterior | NO | NO | V | Serious |
| 1964 | Aufranc[ | 1 | 21 | RTA | Anterior | Posterior | PSF | V | Serious |
| 1968 | Dewey[ | 2 | 32 (31-33) | Crush 1; RTA 1 | Anterior | NO-1; Posterior-1 | NO-1; PD-1 | IV | Serious |
| 1972 | Chaca[ | 1 | 27 | RTA | Posterior | Posterior | PSF | V | Serious |
| 1973 | Henderson[ | 2 | 17.5 (15-20) | Fall 1; RTA 1 | Anterior | Posterior | PSF | IV | Serious |
| 1977 | Newell[ | 1 | 41 | Fall | Anterior | NO | NO | V | Serious |
| 1981 | Das De[ | 4 | 31 (19-54) | Crush | Anterior | Posterior | PSF 2; PD 2 | IV | Serious |
| 1982 | Sciberras[ | 1 | 24 | Crush | Anterior | Posterior | PSF | V | Serious |
| 1983 | Edvardsen[ | 1 | 22 | Crush | Anterior | Anterior | IB | V | Serious |
| 1983 | Nicholson[ | 1 | 28 | RTA | Posterior | Posterior | PSF | V | Serious |
| 1984 | Herron[ | 1 | 22 | Crush | Anterior | Posterior | PSF | V | Serious |
| 1984 | Otani[ | 2 | 22.5 (22-23) | Crush 1; RTA 1 | Anterior | Combined 2 | IB | IV | Serious |
| 1984 | Suomalainen[ | 1 | 17 | RTA | Anterior | Posterior | PSF | V | Serious |
| 1985 | Schnaid[ | 1 | 36 | Crush | Anterior | Posterior | PSF | V | Serious |
| 1988 | Cope[ | 1 | 34 | Fall | Anterior | NO | NO | V | Serious |
| 1991 | Carl[ | 2 | 28.5 (21-36) | Crush 1; Fall 1 | Anterior | Posterior | PSF | IV | Serious |
| 1991 | Ebraheim[ | 1 | 18 | RTA | Anterior | Posterior | PD | V | Serious |
| 1991 | Garin[ | 1 | 14 | RTA | Anterior | Posterior | PSF | V | Serious |
| 1991 | Posel[ | 1 | 70 | RTA | Anterior | Posterior | PSF | V | Serious |
| 1992 | Connolly[ | 4 | 20.25 (16-26) | Crush | Anterior | Posterior | PSF | IV | Serious |
| 1992 | Eyres[ | 1 | 21 | RTA | Anterior | Posterior | PSF | V | Serious |
| 1992 | Osman[ | 1 | 41 | Crush | Anterior | Combined | IB | V | Serious |
| 1993 | Barquet[ | 1 | 24 | Crush | Anterior | Posterior | PSF | V | Serious |
| 1993 | Lee[ | 1 | 32 | Fall | Anterior | Posterior | PD | V | Serious |
| 1995 | Beguiristain[ | 1 | 5 | Crush | Anterior | NO | NO | V | Serious |
| 1997 | Steinitz[ | 1 | 36 | RTA | Posterior | Combined | IB | V | Serious |
| 1998 | Aihara[ | 2 | 23.5 (22-25) | Crush | Anterior | Combined | IB | IV | Serious |
| 1998 | Roche[ | 1 | 25 | RTA | Anterior | Posterior | IB | V | Serious |
| 1999 | Carlson[ | 1 | 15 | RTA | Anterior | Combined | IB | V | Serious |
| 1999 | Fabris[ | 3 | 26.3 (26-27) | RTA | Anterior | Posterior | PSF 1; IB 2 | IV | Serious |
| 1999 | Hodges[ | 1 | 31 | Crush | Anterior | Combined | IB | V | Serious |
| 1999 | Murata[ | 1 | 19 | RTA | Anterior | Posterior | PSF | V | Serious |
| 2001 | Verlaan[ | 1 | 17 | Crush | Anterior | Posterior | IB | V | Serious |
| 2003 | Lamm[ | 1 | 21 | RTA | Anterior | Combined | IB | V | Serious |
| 2003 | Smith[ | 1 | 44 | Crush | Anterior | Posterior | PSF | V | Serious |
| 2003 | Tohme-Noun[ | 1 | 55 | RTA | Anterior | Posterior | IB | V | Serious |
| 2004 | Miyamoto[ | 1 | 20 | RTA | Anterior | NO | NO | V | Serious |
| 2004 | Stuart[ | 1 | 25 | RTA | Anterior | Posterior | PSF | V | Serious |
| 2004 | Tsirikos[ | 2 | 29 (16-42) | RTA | Anterior | Combined | IB | IV | Serious |
| 2004 | Vialle[ | 4 | 36.75 (14-54) | Crush 1; RTA 3 | Anterior | Posterior 3; Combined 1 | PSF 2; IB 2 | IV | Serious |
| 2005 | Ahmed[ | 1 | 34 | RTA | Posterior | Posterior | IB | V | Serious |
| 2005 | Hidalgo-Ovejero[ | 1 | 24 | Crush | Anterior | Posterior | IB | V | Serious |
| 2005 | Robertson[ | 4 | 39 (19-56) | Crush 2; RTA 2 | Anterior | Posterior | PSF 3; IB 1 | IV | Serious |
| 2005 | Song[ | 1 | 47 | RTA | Anterior | Posterior | IB | V | Serious |
| 2005 | Vialle[ | 1 | 27 | RTA | Lateral | Posterior | PSF | V | Serious |
| 2006 | Cho[ | 1 | 26 | RTA | Anterior | Combined | IB | V | Serious |
| 2006 | Ghaiem- Hasakhani[ | 1 | 22 | RTA | Anterior | Posterior | PSF | V | Serious |
| 2006 | Reinhold[ | 1 | 37 | Crush | Anterior | Combined | IB | V | Serious |
| 2007 | El Assuity[ | 1 | 19 | Fall | Anterior | Combined | IB | V | Serious |
| 2007 | Vialle[ | 11 | 34.8 (14-55) | Crush 1; Fall 2; RTA 8 | Anterior 9; Lateral 2 | Posterior 8; Combined 3 | PSF 4; IB 7 | IV | Serious |
| 2008 | De Iure[ | 1 | 34 | RTA | Lateral | Posterior | IB | V | Serious |
| 2008 | Deniz[ | 1 | 44 | RTA | Anterior | Posterior | IB | V | Serious |
| 2008 | Reddy[ | 2 | 35 (23-47) | Crush 1; RTA 1 | Anterior | Posterior | PSF | IV | Serious |
| 2008 | Szentirmai[ | 1 | 14 | RTA | Anterior | Posterior | PSF | V | Serious |
| 2009 | Lim[ | 3 | 48.3 (41-56) | Crush 2; Fall 1 | Anterior | Posterior | PSF 1; IB 2 | IV | Serious |
| 2010 | Blecher[ | 1 | 20 | Crush | Anterior | Posterior | IB | V | Serious |
| 2010 | Hidalgo-Ovejero[ | 1 | 40 | Crush | Anterior | Posterior | PSF | V | Serious |
| 2011 | Fang[ | 1 | 26 | RTA | Anterior | Posterior | IB | V | Serious |
| 2011 | Soultanis[ | 1 | 19 | RTA | Anterior | Posterior | PSF | V | Serious |
| 2011 | Xu[ | 1 | 23 | Crush | Anterior | Posterior | IB | V | Serious |
| 2012 | Catana[ | 2 | 31 (26-36) | RTA | Anterior | Posterior | IB | IV | Serious |
| 2012 | Im[ | 1 | 37 | Crush | Anterior | Posterior | IB | V | Serious |
| 2012 | Shinohara[ | 1 | 18 | RTA | Anterior | Posterior | IB | V | Serious |
| 2013 | Guo[ | 1 | 66 | Crush | Anterior | Posterior | IB | V | Serious |
| 2013 | Nakao[ | 1 | 47 | Crush | Lateral | Posterior | PSF | V | Serious |
| 2013 | Rodrigues[ | 1 | 15 | Crush | Anterior | Combined | IB | V | Serious |
| 2013 | Tang[ | 1 | 41 | Crush | Anterior | Posterior | IB | V | Serious |
| 2014 | Onu[ | 1 | 20 | RTA | Posterior | Posterior | PSF | V | Serious |
| 2014 | Padalkar[ | 1 | 25 | Crush | Anterior | Posterior | IB | V | Serious |
| 2014 | Tang[ | 5 | 38.4 (31-46) | Crush 1; RTA 4 | Anterior | Posterior | IB | IV | Serious |
| 2015 | Robbins[ | 2 | 36 (23-49) | Crush 1; RTA 1 | Anterior 1; Posterior 1 | Posterior | IB | IV | Serious |
| 2015 | Tang[ | 1 | 38 | RTA | Anterior | Posterior | IB | V | Serious |
| 2015 | Yang[ | 1 | 11 | Crush | Anterior | Posterior | PSF | V | Serious |
| 2015 | Yazdi[ | 1 | 16 | Fall | Anterior | Posterior | PSF | V | Serious |
| 2016 | Zenonos[ | 1 | 36 | RTA | Anterior | Posterior | PSF | V | Serious |
| Case Series | 9 | 31.1 (13-58) | Crush 1; Fall 3; RTA 5 | Anterior 9 | NO 1; Posterior 7; Combined 1 | NO 1; PSF 5; IB 3 | |||
| Case 1 | 18 | RTA | Anterior | Posterior | PSF | ||||
| Case 2 | 19 | RTA | Anterior | Posterior | IB | ||||
| Case 3 | 30 | RTA | Anterior | Posterior | PSF | ||||
| Case 4 | 18 | Crush | Anterior | Posterior | PSF | ||||
| Case 5 | 58 | Fall | Anterior | Posterior | PSF | ||||
| Case 6 | 39 | Fall | Anterior | Combined | IB | ||||
| Case 7 | 13 | Fall | Anterior | Posterior | IB | ||||
| Case 8 | 34 | RTA | Anterior | Posterior | PSF | ||||
| Case 9 | 51 | RTA | Anterior | NO | NO | ||||
| Total | 77 included articles with present case series | N = 125 | 30.53 (5-70); male = 89 (71.2%); female = 36 (28.8%) | Crush = 45 (36%); fall = 14 (11.2%); RTA = 66 (52.8%) | Anterior = 110 (88.0%); posterior = 7 (5.6%); lateral = 5 (4.0%) | NO = 8 (6.4%); posterior = 97 (77.6%); anterior = 1 (0.8%); combined = 19 (15.2%) | NO = 8 (6.4%); PD = 5 (4.0%); PSF = 54 (43.2%); IB = 58 (46.4%) |
Abbreviations: RTA, road traffic accident; NO, nonoperative; PD, posterior decompression; PSF, posterior spinal instrumentation + fusion; IB, interbody fusion with supplemental posterior instrumentation ± fusion.
a Level of evidence: I, randomized controlled trial; II, prospective cohort study; III, case-control or retrospective cohort study; IV, case series with no control group; V, expert opinion or case reports.
b Overall risk for bias: Low, comparable to a well-performed randomized trial; Moderate, nonrandomized study but cannot be considered comparable to a well-performed randomized trial; Serious, has some important problems; Critical, too problematic to provide any useful evidence and should not be included in any synthesis; No information, no information to base a judgement about risk of bias.
Preoperative and Postoperative Characteristics of Patient Cases Stratified Based on Treatment Type.
| Preoperative Data (N = 125) | N (%) | NO (n, %) | PD (n, %) | PSF (n, %) | IB (n, %) | |
|---|---|---|---|---|---|---|
| Levels involved (N = 125) | T12-L1 | 1 (0.8%) | 1 (0.8%) | |||
| L1-L2 | 7 (5.6%) | 5 (4.1%) | 2 (1.6%) | |||
| L2-L3 | 3 (2.4%) | 1 (0.8%) | 2 (1.6%) | |||
| L3-L4 | 9 (7.2%) | 7 (5.7%) | 2 (1.6%) | |||
| L4-L5 | 9 (7.2%) | 2 (1.6%) | 7 (5.7%) | |||
| L5-S1 | 93 (74.4%) | 7 (5.7%) | 5 (4.1%) | 37 (30.3%) | 44 (36.1%) | |
| Cauda equina | 13 (10.4%) | 3 (2.4%) | 10 (8%) | |||
| Multiply injured | 81 (64.8%) | 5 (4%) | 3 (2.4%) | 40 (32%) | 33 (26.4%) | |
| Disc lesion (N = 43) | 43 (34.4%) | 1 (2.3%) | 1 (2.3%) | 11 (25.6%) | 30 (69.8%) | |
| Listhesis—low grade (N = 112) | Grade 0 | 2 (1.6%) | 1 (0.9%) | 1 (0.9%) | ||
| Grade 1 | 30 (24%) | 3 (2.7%) | 1 (0.9%) | 15 (13.4%) | 11 (9.8%) | |
| Grade 2 | 49 (39.2%) | 3 (2.7%) | 1 (0.9%) | 16 (14.3%) | 29 (25.9%) | |
| Listhesis—high grade | Grade 3 | 18 (14.4%) | 2 (1.8%) | 9 (8%) | 7 (6.3%) | |
| Grade 4 | 13 (10.4%) | 5 (4.5%) | 8 (7.1%) | |||
| Dimar classification | 1 Facet dislocation | 31 (24.8%) | 1 (3.2%) | 2 (6.5%) | 9 (29%) | 19 (61.3%) |
| 2 Facet fracture | 33 (26.4%) | 1 (3%) | 1 (3%) | 14 (42.4%) | 17 (51.5%) | |
| 3 Pars fracture | 10 (8.0%) | 1 (10%) | 4 (40%) | 5 (50%) | ||
| 4 Fusion mass fracture | 0 (0%) | |||||
| 5 Pedicle fracture | 13 (10.4%) | 2 (15.4%) | 7 (53.8%) | 4 (30.8%) | ||
| 6 Complex + Body fracture | 34 (27.2%) | 3 (8.8%) | 20 (58.8%) | 11 (32.4%) | ||
| Postoperative Data | N (%) | NO (n, %) | PD (n, %) | PSF (n, %) | IB (n, %) | |
| Time to surgery, days (N = 107, mean ± SD) | 29.47 ± 64.64 (0-420) | 22 ± 27 (0-60) | 19 ± 36 (0-150) | 41 ± 85 (0-420) | ||
| Follow-up period, months (N = 122, mean ± SD) | 27.2 ± 26.4 (1-120) | 22.06 ± 31.68 (1-96) | 64 ± 64.75 (4-120) | 28.41 ± 27.09 (1-120) | 24.20 ± 18.74 (3-84) | |
| Bracea,b | Bracing done | 50 (40%) | 7 (5.6%) | 3 (2.4%) | 27 (21.6%) | 13 (10.4%) |
| No brace | 75 (60%) | 1 (0.8%) | 2 (1.6%) | 27 (21.6%) | 45 (36.0%) | |
| Brace period (months) (N = 49, mean ± SD) | 3.24 ± 3.29 (0.5-24) | 5.93 ± 8.15 (0.5-24) | 1.67 ± 0.58 (1-2) | 2.84 ± 1.07 (1.25-6) | 2.96 ± 1.62 (1-6) | |
| Complicationsc | Complications | 28 (22.4%) | 3 (2.4%) | 4 (3.2%) | 12 (9.6%) | 9 (7.2%) |
| No complications | 97 (77.6%) | 5 (4%) | 1 (0.8%) | 42 (33.6%) | 49 (39.2%) | |
| Presentation, months (N = 28, mean ± SD) | 13.3 ± 23.6 (0-96) | 13.3 ± 10.5 (3-24) | 3.0 ± 6.0 (0-12) | 23.1 ± 33.1 (0.3-96) | 4.9 ± 7.2 (0-21) | |
Abbreviations: NO, nonoperative; PD, posterior decompression; PSF, posterior spinal instrumentation + fusion; IB, interbody fusion with supplemental posterior instrumentation ± fusion.
a Significant difference with bracing use between treatment types using Pearson χ2 test (χ2[3] = 18.078, P < .001).
b Significant difference between PSF and IB fusion with the Pearson χ2 test (χ2[1] = 9.269, P = .002).
c Significant difference with presence of complications between treatment types using Pearson χ2 test (χ2[6] = 17.023, P = .009).
Outcome Data Stratified Based on Treatment Type.
| Outcomes (N = 125) | Preoperative Total (n, %) | Postoperative Total (n, %) | NO (n, %) | PD (n, %) | PSF (n, %) | IB (n, %) | |
|---|---|---|---|---|---|---|---|
| Fusion (N = 124)a,b | Fusion | 92 (73.6%) | 3 (37.5%) | 1 (25%) | 37 (68.5%) | 51 (87.9%) | |
| No fusion | 32 (25.6%) | 5 (62.5%) | 3 (75%) | 17 (31.5%) | 7 (12.1%) | ||
| Ambulation (N = 124) | Ambulatory | 118 (94.4%) | 7 (87.5%) | 4 (100%) | 51 (94.4%) | 56 (96.6%) | |
| Nonambulatory | 6 (4.8%) | 1 (12.5%) | 3 (5.6%) | 2 (3.4%) | |||
| Painc | (+) Pain | 103 (82.4%) | 25 (20.0%) | 3 (37.5%) | 1 (25%) | 9 (16.7%) | 12 (20.70%) |
| No pain report | 99 (80%) | 5 (62.5%) | 3 (75%) | 45 (83.3%) | 46 (79.30%) | ||
| Neurologic deficits overallc | (+) Deficits | 63 (50.4%) | 31 (24.8%) | 2 (25%) | 0 | 15 (27.8%) | 14 (24.10%) |
| Normal | 93 (74.4%) | 6 (75%) | 4 (100%) | 39 (72.2%) | 44 (75.9%) | ||
| ASIA scorec | A | 2 (1.6%) | 1 (0.8%) | 1 (0.8%) | |||
| B | 3 (2.4%) | 0 (0%) | |||||
| C | 36 (28.8%) | 15 (8.0%) | 1 (0.8%) | 5 (4.0%) | 4 (3.2%) | ||
| D | 15 (12.0%) | 15 (12.0%) | 8 (6.4%) | 7 (5.6%) | |||
| E | 67 (53.6%) | 96 (76.8%) | 7 (5.6%) | 4 (3.2%) | 40 (32%) | 45 (36%) | |
| Sensoryc | 0 | 6 (4.8%) | 1 (0.8%) | 1 (0.8%) | |||
| 1 | 52 (41.6%) | 26 (20.8%) | 2 (1.6%) | 13 (10.4%) | 11 (8.8%) | ||
| 2 | 65 (52%) | 95 (76.0%) | 6 (4.8%) | 4 (3.2%) | 40 (32%) | 45 (36%) | |
| Bladder symptomsc | (+) Bladder | 26 (20.8%) | 4 (3.2%) | 2 (3.70%) | 2 (3.4%) | ||
| None | 120 (96%) | 8 (100%) | 4 (100%) | 52 (96.3%) | 56 (96.6%) | ||
| Bowel symptomsc | (+) Bowel | 23 (18.4%) | 5 (4.0%) | 3 (5.6%) | 2 (3.4%) | ||
| None | 119 (95.20%) | 8 (100%) | 4 (100%) | 51 (94.4%) | 56 (96.6%) | ||
Abbreviations: NO, nonoperative; PD, posterior decompression; PSF, posterior spinal instrumentation + fusion; IB, interbody fusion with supplemental posterior instrumentation ± fusion.
a Significant difference in fusion outcomes between treatment types with Pearson χ2 test (χ2[3] = 17.306, P = .001).
b Significant difference in fusion outcomes between PSF and IB based on Pearson χ2 test (χ2[1] = 6.259, P = .012).
c Significant difference between preoperative and postoperative variables on related samples Wilcoxon signed ranks test, with P < .001 (Z scores: pain Z = −8.556; neurologic deficits overall Z = −5.578; ASIA score Z = −6.026; sensory Z = −5.466; bladder symptoms Z = −4.690; bowel symptoms Z = −4.243).
Figure 3.Patient 1 was an 18-year-old male who came in after a road traffic accident. He presented with severe back pain but was neurologically intact, and he had an associated left femur fracture. (A) CT image with acute bilateral pars fracture at L2 (Dimar classification Type 3). Grade 1 anterior listhesis on radiographs (not shown) reduces on supine position. Note the chronic spondylolysis at L5. (B) No disc injuries noted on T2-weighted MRI scan, but had acute injuries to the interspinous ligament at L1-L2 and L2-L3. (C) Posterior spinal instrumentation with posterolateral fusion was done from L1-L3 after reduction. Maintenance of instrumentation and fusion was documented, with no reported pain or deficits on last follow-up 4 years post injury.
Figure 4.Patient 2 was a 19-year-old male involved in a road traffic accident who was neurologically intact with associated left scapula and right sacral fracture. (A) CT image showing L5-S1 bilateral facet dislocation (Dimar classification Type 1) with grade 3 anterior listhesis. (B) Disc injury seen on T2-weighted MRI scan. (C) Interbody fusion with supplemental posterior instrumentation and fusion was performed at L5-S1. On last follow-up at 1 year post injury, patient was ambulatory without complaints of pain and neurologic deficits, and had documented fusion.
Outcome Subanalysis of Patients With Identified Disc Lesions Stratified Based on Posterior Spinal Instrumentation + Fusion (PSF) or Interbody Fusion With Supplemental Posterior Fixation ± Fusion (IB).
| Outcomes (N = 41) | Preoperative Total (n, %) | Postoperative Total (n, %) | PSF (n, %) | IB (n, %) | |
|---|---|---|---|---|---|
| Fusiona | Fusion | 31 (75.6%) | 5 (45.5%) | 26 (86.7%) | |
| No fusion | 10 (24.4%) | 6 (54.5%) | 4 (13.3%) | ||
| Ambulationb | Ambulatory | 39 (95.1%) | 9 (81.8%) | 30 (100%) | |
| Nonambulatory | 2 (4.9%) | 2 (18.2%) | 0 (0%) | ||
| Painc | (+) Pain | 38 (88.4%) | 9 (22%) | 2 (18.2%) | 7 (23.3%) |
| No pain report | 5 (11.6%) | 32 (78.0%) | 9 (81.8%) | 23 (76.7%) | |
| Neurologic deficits overallc | (+) Deficits | 29 (67.4%) | 12 (29.3%) | 5 (45.5%) | 7 (23.3%) |
| Normal | 14 (32.6%) | 29 (70.7%) | 6 (54.5%) | 23 (76.7%) | |
Abbreviations: PSF, posterior spinal instrumentation + fusion; IB, interbody fusion with supplemental posterior instrumentation ± fusion.
a Significant difference in fusion outcomes between PSF and IB based on Pearson χ2 tests (χ2[1] = 7.413, P = .006).
b Significant difference in ambulation between PSF and IB based on Pearson χ2 tests (χ2[1] = 5.734, P = .017).
c Significant difference between preoperative and postoperative variables on related samples Wilcoxon signed ranks test, with P < .001 (Z scores: pain Z = −5.014, neurologic deficits overall Z = −4.00).
Outcome Subanalysis of Patients Without Disc Lesions Stratified Based on Posterior Spinal Instrumentation + Fusion (PSF) or Interbody Fusion With Supplemental Posterior Fixation ± Fusion (IB).
| Outcomes (N = 71) | Preoperative Total (n, %) | Postoperative Total (n, %) | PSF (n, %) | IB (n, %) | |
|---|---|---|---|---|---|
| Fusiona | Fusion | 57 (80.3%) | 32 (74.4%) | 25 (89.3%) | |
| No fusion | 14 (19.7%) | 11 (25.6%) | 3 (10.7%) | ||
| Ambulationa | Ambulatory | 68 (95.8%) | 42 (97.7%) | 26 (92.9%) | |
| Nonambulatory | 3 (4.2%) | 1 (2.3%) | 2 (7.1%) | ||
| Paina,b | (+) Pain | 54 (76.1%) | 12 (16.9%) | 7 (16.3%) | 5 (17.9%) |
| No pain report | 17 (23.9%) | 59 (83.1%) | 36 (83.7%) | 23 (82.1%) | |
| Neurologic deficits overalla,b | (+) Deficits | 29 (42%) | 17 (23.9%) | 10 (23.3%) | 7 (25%) |
| Normal | 40 (58%) | 54 (76.1%) | 33 (76.7%) | 21 (75%) | |
Abbreviations: PSF, posterior spinal instrumentation + fusion; IB, interbody fusion with supplemental posterior instrumentation ± fusion.
a No significant difference in outcomes between PSF and IB based on Pearson χ2 tests (P > .05).
b Significant difference between preoperative and postoperative variables on related samples Wilcoxon signed ranks test, with P < .001 (Z scores: pain Z = −6.33, neurologic deficits overall Z = −3.55).
Outcome Subanalysis of Patients Stratified Based on Proposed Classification.
| Postoperative Outcomes (N = 121) | I— Facet Dislocation (n, %) | II—Facet Fracture (n, %) | III—Pars Fracture (n, %) | IV—Fusion Mass (n, %) | V—Pedicle Fracture (n, %) | VI—Complex Fracture (n, %) | |
|---|---|---|---|---|---|---|---|
| Fusion | Fusion | 24 (77.4%) | 27 (81.8%) | 8 (80%) | 11 (84.6%) | 20 (58.8%) | |
| No fusion | 7 (22.6%) | 6 (18.2%) | 2 (20%) | 2 (15.4%) | 14 (41.2%) | ||
| Ambulation | Ambulatory | 29 (93.5%) | 33 (100%) | 10 (100%) | 13 (100%) | 30 (88.2%) | |
| Nonambulatory | 2 (6.5%) | 4 (11.8%) | |||||
| Paina | (+) Pain | 5 (16.1%) | 7 (21.2%) | 6 (46.2%) | 4 (11.8%) | ||
| No pain report | 26 (83.9%) | 26 (78.8%) | 10 (100%) | 7 (53.8%) | 30 (88.2%) | ||
| Neurologic deficits overall | (+) Deficits | 4 (12.9%) | 8 (24.2%) | 1 (10%) | 5 (38.5%) | 12 (35.3%) | |
| Normal | 27 (87.1%) | 25 (75.8%) | 9 (90%) | 8 (61.5%) | 22 (64.7%) | ||
a Significant difference in postoperative pain between groups based on Pearson χ2 test (χ2[4] = 10.293, P = .036).